Ascendis Pharma A (ASND) Interest & Investment Income (2014 - 2026)
Ascendis Pharma A (ASND) recorded Interest & Investment Income of $23.21 million in the quarter ended Jun 30, 2026, down 62.8% from $62.32 million a year earlier but up 338.8% from the prior quarter.
Ascendis Pharma A (ASND) Interest & Investment Income (2014 - 2026) Analysis & Trends
On a TTM basis, Ascendis Pharma A's Interest & Investment Income came in at $63.56 million as of Jun 30, 2026, down 70.0% year-over-year; for the year ended Dec 31, 2025, it was $268.15 million, up 163.1% from the prior year.
- Annual Interest & Investment Income has a five-year compound annual growth rate of 162.3% (years ended Dec 2020 to Dec 2025).
- Across earlier years, Interest & Investment Income came in at $101.93 million in the year ended Dec 31, 2024 (+114.9%), $47.44 million in the year ended Dec 31, 2023 (-13.7%), $55 million in the year ended Dec 31, 2022 (-19.5%) and $68.32 million in the year ended Dec 31, 2021.
- Quarterly Interest & Investment Income has ranged from $3.37 million in the quarter ended Dec 31, 2022 to $88.01 million in the quarter ended Dec 31, 2024 over the past five years.
- On a year-over-year basis, Interest & Investment Income has declined for four consecutive quarters, with growth averaging 139.6% over the last eight quarters.
- Peak year-over-year performance for Interest & Investment Income in the last five years was growth of 681.5% in the quarter ended Mar 31, 2025, against a decline of 92.0% in the quarter ended Mar 31, 2024 at the low end.
- Per Business Quant, the preceding three quarters came in at $5.29 million (quarter ended Mar 31, 2026), $28.01 million (quarter ended Dec 31, 2025) and $7.06 million (quarter ended Sep 30, 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 219.00 Mn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | - |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 80.00 Mn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | - |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | - |
| 10 | Ascendis Pharma A | 14.12 Bn | 10.37 Bn | 362.22 Mn | 23.21 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 23.21 Mn |
| Mar 31, 2026 | 5.29 Mn |
| Dec 31, 2025 | 28.01 Mn |
| Sep 30, 2025 | 7.06 Mn |
| Jun 30, 2025 | 62.32 Mn |
| Mar 31, 2025 | 30.35 Mn |
| Dec 31, 2024 | 88.01 Mn |
| Sep 30, 2024 | 31.06 Mn |
| Jun 30, 2024 | 52.82 Mn |
| Mar 31, 2024 | 3.88 Mn |
| Dec 31, 2023 | 40.15 Mn |
| Sep 30, 2023 | 4.51 Mn |
| Jun 30, 2023 | 38.94 Mn |
| Mar 31, 2023 | 48.45 Mn |
| Dec 31, 2022 | 3.37 Mn |
| Sep 30, 2022 | 20.49 Mn |
| Jun 30, 2022 | 75.90 Mn |
| Mar 31, 2022 | 14.64 Mn |
| Dec 31, 2021 | 24.95 Mn |
| Sep 30, 2021 | 25.14 Mn |
Ascendis Pharma A Interest & Investment Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=ASND&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "interest-and-investment-income", "ticker": "ASND", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=ASND&period=max&api_key=YOUR_API_KEY");
const data = await res.json();